benzoxazoles has been researched along with Tauopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirao, K; Ibrahim, NF; Kato, T; Morikawa, S; Shirai, N; Sogabe, T; Taguchi, H; Tooyama, I; Yanagisawa, D | 1 |
| Baron, T; Billard, T; Bouillot, C; Chauveau, F; Lancelot, S; Levigoureux, E; Verchere, J; Verdurand, M; Zimmer, L | 1 |
2 other study(ies) available for benzoxazoles and Tauopathies
| Article | Year |
|---|---|
Fluorine-19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice.
Topics: Aged; Alzheimer Disease; Animals; Benzoxazoles; Brain; Butadienes; Disease Models, Animal; Female; Fluorine; Fluorine-19 Magnetic Resonance Imaging; Humans; Male; Mice; Mice, Transgenic; Neurofibrillary Tangles; tau Proteins; Tauopathies | 2018 |
Binding of the PET radiotracer [¹⁸F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice.
Topics: alpha-Synuclein; Animals; Benzoxazoles; Brain Stem; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Radioligand Assay; Tauopathies; Thalamus; Thiazoles | 2014 |